Donates Lullaby Warmers to 8 Children's hospitals in India.
Chennai, May 29, 2009: GE Healthcare, the US$17 billion healthcare and life sciences solutions business of global major General Electric Company (NYSE: GE) donated a Lullaby Warmer each to eight selected children's hospitals across India. The donation is part of GE's 'healthymagination' initiative which aims to improve costs, quality and access to affordable healthcare,
New collaboration aims to improve outcomes, lower procedure times, and eliminate radiation exposure
Waukesha, wi, April 28, 2009 - GE Healthcare and Imricor Medical Systems announced today their agreement to co-develop a radiation-free cardiac EP offering. The alliance combines leading technology -- GE's MR platform and Imricor's devices and systems -- to provide a revolutionary MR-guided, catheter-based EP technique that improves outcomes, lowers procedure time and eliminates ionizing radiation exposure for patients and clinicians.
Expanded Medicare coverage of PET scans improves access for patients to needed cancer diagnosis tool
WAUKESHA, WIS. -- APRIL 07, 2009 -- GE Healthcare, a global leader in healthcare technology, supports the recent national coverage determination (NCD) from the Centers for Medicare and Medicaid Services (CMS), expanding coverage for initial testing with positron emission tomography (PET) for Medicare beneficiaries who are diagnosed with and treated for most solid tumor cancers.
http://www.gehealthcare.com/usen/telehealth/quietcare/proactive_eldercar...
GE Healthcare provides more information on the QuietCare®.
http://www.intel.com/go/healthguide
The Intel® Health Guide is meant to be a powerful care management tool for healthcare professionals who manage patients with long-term (chronic) conditions.
ORLANDO, Fla.--(BUSINESS WIRE)--GE Healthcare, a unit of General Electric Company (NYSE: GE), presented results from the ADMIRE-HF study at the American College of Cardiology's 58th Annual Scientific Session in Orlando, Florida today. The study involved a nuclear imaging test utilizing the imaging agent AdreView™ (Iobenguane I 123 injection) in heart failure patients who are at a higher risk for cardiac death, disease progression, or cardiac arrhythmias.
ADMIRE-HF Data
